Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy
about
sameAs
Idiopathic pulmonary fibrosis.Reactive oxygen species-mediated p38 MAPK regulates carbon nanotube-induced fibrogenic and angiogenic responsesPhosphatidylinositol-3-Kinase/Akt regulates bleomycin-induced fibroblast proliferation and collagen productionCorticosteroids for idiopathic pulmonary fibrosisImmunomodulatory agents for idiopathic pulmonary fibrosisWNT5A is a regulator of fibroblast proliferation and resistance to apoptosisRegulation of pulmonary fibrosis by chemokine receptor CXCR3Inhibition and role of let-7d in idiopathic pulmonary fibrosisRegulation of transforming growth factor-β1-driven lung fibrosis by galectin-3Feedback amplification of fibrosis through matrix stiffening and COX-2 suppressionThe 6 minute walk in idiopathic pulmonary fibrosis: longitudinal changes and minimum important differenceWNT1-inducible signaling protein-1 mediates pulmonary fibrosis in mice and is upregulated in humans with idiopathic pulmonary fibrosisClassification and natural history of the idiopathic interstitial pneumoniasA new direction in the pathogenesis of idiopathic pulmonary fibrosis?Growth factors in idiopathic pulmonary fibrosis: relative rolesIdiopathic pulmonary fibrosis: an epithelial/fibroblastic cross-talk disorderThe absence of reactive oxygen species production protects mice against bleomycin-induced pulmonary fibrosisGene expression profiling reveals novel TGFbeta targets in adult lung fibroblastsFibroblasts and monocyte macrophages contract and degrade three-dimensional collagen gels in extended co-cultureFocusing on diffuse (interstitial) lung disease: a rapidly evolving fieldCD8+ T lymphocytes in lung tissue from patients with idiopathic pulmonary fibrosisExpression of HSP47 in usual interstitial pneumonia and nonspecific interstitial pneumonia.Is neutrophil elastase the missing link between emphysema and fibrosis? Evidence from two mouse models.The role of pro- and anti-inflammatory responses in silica-induced lung fibrosis.TGF-beta1 induces human alveolar epithelial to mesenchymal cell transition (EMT)Up-regulation and profibrotic role of osteopontin in human idiopathic pulmonary fibrosisClearance of technetium-99m-DTPA and HRCT findings in the evaluation of patients with Idiopathic Pulmonary Fibrosis.Pirfenidone in the treatment of idiopathic pulmonary fibrosis: an evidence-based review of its place in therapyInvolvement of matrix metalloproteinases (MMPs) and inflammasome pathway in molecular mechanisms of fibrosisPatient considerations and drug selection in the treatment of idiopathic pulmonary fibrosisAeroparticles, Composition, and Lung DiseasesNintedanib: evidence for its therapeutic potential in idiopathic pulmonary fibrosisEMT and interstitial lung disease: a mysterious relationshipGammaherpesviruses and pulmonary fibrosis: evidence from humans, horses, and rodentsEfficacy and safety of pirfenidone for idiopathic pulmonary fibrosisMolecular classification of idiopathic pulmonary fibrosis: personalized medicine, genetics and biomarkersThe Rho kinases: critical mediators of multiple profibrotic processes and rational targets for new therapies for pulmonary fibrosisHydrogen Sulfide as a Potential Therapeutic Target in FibrosisAngiotensin signalling in pulmonary fibrosisMolecular biomarkers in idiopathic pulmonary fibrosis
P2860
Q21202895-907B2573-46E1-4F5A-B06C-B8792815CBBCQ23918832-8AA66333-FA06-47A0-B587-E7D9EB50561DQ23924071-341CE5C9-B47A-4A0B-8600-E500EEDFC326Q24247945-9A4BB708-A0D2-4048-B98B-1195C94253B1Q24248714-65FA0680-F1C3-4C07-BA35-85A5891DD334Q24316338-3608D75C-C516-4C30-A9C4-1557D3B60F7FQ24563456-5D8A8DD1-4EDD-469B-88A9-28BF16829A32Q24599153-9793364A-C523-4E48-871C-E5E97CCEF2F0Q24624887-840C0921-99CC-4151-9756-B7B6957893EEQ24627446-53B781AD-1142-4873-81BD-07F50033847FQ24628952-E5D39048-264F-4D46-B2BF-F7881EA4110BQ24650922-5B28AE3B-74B5-486B-B695-0DB5DD67ECE9Q24655062-988B4585-253D-4B85-9764-1FF3A6E31424Q24798888-EA4968F8-0C81-40AE-90F8-97889D0516E8Q24798972-7BE3AD12-AA9D-44D8-9D6B-3963BE7E528EQ24799045-301F57F5-41ED-40CC-A92D-286B8C417190Q24803487-83159BA9-F36C-4CCF-B95B-1ECB59A110B0Q24804612-B6DF0580-4782-41C9-A148-4AAC39F7B9ECQ24806771-9D73FDD2-1A48-4AE1-A6F4-7BF9E8E1590EQ24807129-9F48D402-43B4-4C8A-BAF8-BDA10A4B01ECQ24811707-356E6E33-76EB-4A23-BC61-E3BFF8163AA8Q24811876-87D42F7B-0B00-4A5F-AFC7-93564652A6F4Q24812352-C65D63A3-BD28-4045-8DD7-69C3170AD947Q24812428-CB236B72-E345-421B-81B5-DBA2F0F0B111Q24813751-69D33A36-BFDE-4128-BD3D-BB91562A2582Q24817140-833A64B9-6405-40C3-B746-E00D0A1E08C7Q25256904-7E64CAF4-DBC9-4487-B84D-C863ED058A41Q26738458-16768DCE-DCAA-4AE6-92F4-E5B9C89E34C3Q26744390-677B96AC-CE20-426B-9932-08824EBA24E2Q26750418-144ABAA5-4144-47C9-9CB3-7C92679E5251Q26772710-403E1EE1-CD0C-490C-9E47-9E9D991C7689Q26783169-FF7E188A-64CA-4EDC-9299-3DE2750FCB13Q26824760-DD0CECA1-ED49-4CB4-87CA-A661C42AD318Q26829291-A8898E82-2C70-4120-9CF0-9298BFCEA77AQ26849378-06507423-6FE9-4225-B4B0-9B19DEFACB52Q26864836-27AE66F7-41AE-4512-BE5F-94741E40B391Q27005980-0BCCF314-002D-483A-88B8-32957197AF24Q27011111-A741716F-83C1-4CF7-9005-5E8BE9F092BDQ27025157-71CD894F-F136-4B88-8223-AFFFD4F845BEQ27025340-BA829596-D080-4D4E-A87C-518C9D271AA6
P2860
Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Idiopathic pulmonary fibrosis: ...... s and implications for therapy
@ast
Idiopathic pulmonary fibrosis: ...... s and implications for therapy
@en
Idiopathic pulmonary fibrosis: ...... s and implications for therapy
@nl
type
label
Idiopathic pulmonary fibrosis: ...... s and implications for therapy
@ast
Idiopathic pulmonary fibrosis: ...... s and implications for therapy
@en
Idiopathic pulmonary fibrosis: ...... s and implications for therapy
@nl
prefLabel
Idiopathic pulmonary fibrosis: ...... s and implications for therapy
@ast
Idiopathic pulmonary fibrosis: ...... s and implications for therapy
@en
Idiopathic pulmonary fibrosis: ...... s and implications for therapy
@nl
P2093
P921
P3181
P1476
Idiopathic pulmonary fibrosis: ...... s and implications for therapy
@en
P2093
P304
P3181
P356
10.7326/0003-4819-134-2-200101160-00015
P407
P577
2001-01-16T00:00:00Z